Use the Back button in your browser to see the other results of your search or to select another record.
| Does Kinesiotaping increase the efficacy of lidocaine injection in myofascial pain syndrome treatment? A randomized controlled study |
| Ata E, Kosem M, Adiguzel E |
| Journal of Back and Musculoskeletal Rehabilitation 2019;32(3):471-477 |
| clinical trial |
| 6/10 [Eligibility criteria: No; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: Yes; Adequate follow-up: Yes; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
|
BACKGROUND: Myofascial pain syndrome is a common form of musculoskeletal disorder that originates from a painful site in a muscle or related fascia. There are various non-invasive and invasive treatment methods. OBJECTIVE: To investigate the efficacy of myofascial trigger point Kinesiotaping with that of local anesthetic injection alone on the degree of pain and quality of life in myofascial pain syndrome. METHODS: Seventy-six patients with myofascial pain syndrome were randomly assigned to three study groups. Group 1 (n = 26) received only local anesthetic (1 ml lidocaine of 0.5% for each trigger point) injection. Group 2 (n = 25) received local anesthetic injection plus sham Kinesiotaping. Group 3 (n = 25) received local anesthetic injection plus Kinesiotaping. Pain intensity was measured by visual analog scale (VAS) at baseline, immediately after treatment, and in the 1st and 4th week post-treatment. To evaluate the effect of treatment on quality of life, Short Form-12 (SF-12) was used at baseline and at 4th week post-treatment. RESULTS: Group 3 showed significantly more improvement than other groups at post-treatment VAS, SF-12 physical component evaluations (p < 0.05). No significant difference was found between groups 2 and 3 in the mental component of SF-12 (p > 0.05), but the patients in group 3 performed significantly better than group 1 (p < 0.05). No significant difference was found between groups 1 and 2 in VAS, SF12 Physical Components Summary and SF-12 Mental Components Summary Scores at post-treatment evaluations. CONCLUSION: This study indicated that Kinesiotaping may be useful to increase the efficacy of myofascial trigger point lidocaine injection in myofascial pain syndrome.
|